Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-13

Clinical Trial Update: Endoscopic Variceal Ligation vs Carvedilol for the Prevention of First Esophageal Variceal Bleeding in Patients With HCC [Phase 4]

View source ↗

Summary

This Phase 4 trial compares endoscopic variceal ligation versus carvedilol to prevent first esophageal variceal bleeding in patients with hepatocellular carcino…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CARVEDILOL (Carvedilol)

Snippet

Sponsor: Taipei Veterans General Hospital, Taiwan | Conditions: Hepatocellular Carcinoma (HCC), Esophageal Varices | Phase 4 | Status: RECRUITING